Submit Your Feeds

Business News • 1888 Press Release • Biogenum Presents Data on Symptom Improvement by BGM-27 Immunotherapy Targeting pTau on Negative Symptoms, Depression, and Social Function in Patients with Alzheimer

Biogenum Presents Data on Symptom Improvement by BGM-27 Immunotherapy Targeting pTau on Negative Symptoms, Depression, and Social Function in Patients with Alzheimer

Biogenum Presents Data on Symptom Improvement by BGM-27 Immunotherapy Targeting pTau on Negative Symptoms, Depression, and Social Function in Patients with Alzheimer

The data will be presented at the Asian Society of Alzheimer Prevention (ASAP) Annual Meeting.

View More : https://www.1888pressrelease.com/biogenum-presents-data-on-symptom-improvement-by-bgm-27-immu-pr-666952.html

Releted News by 1888pressrelease

Lightstec Explains 4 Things You Need to Know Before Buying LED Aluminum Profiles

Biogenum Appoints Kang Tae-suk as Senior Vice President, Head of Regulatory Affairs

Biogenum Funds Expansion of Cognition Study in Running Birth Cohort

Biogenum Presents Data on Symptom Improvement by BGM-27 Immunotherapy Targeting pTau on Negative Symptoms, Depression, and Social Function in Patients with Alzheimer

Biogenum Presents Periodic Corporate Update

Biogenum Receives $1 Million Grant to Enhance Psychosocial Research for Dementia Care